Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,648 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact.
Huebner H, Wimberger P, Laakmann E, Ruckhäberle E, Ruebner M, Lehle S, Uhrig S, Ziegler P, Link T, Hack CC, Belleville E, Faull I, Hausch M, Wallwiener D, Schneeweiss A, Tesch H, Brucker SY, Beckmann MW, Fasching PA, Müller V, Fehm TN. Huebner H, et al. Among authors: muller v. Precis Clin Med. 2024 Dec 24;8(1):pbae034. doi: 10.1093/pcmedi/pbae034. eCollection 2025 Mar. Precis Clin Med. 2024. PMID: 39839709 Free PMC article.
Acetogenesis to ethanologenesis: facilitating NADH oxidation via reductive acetate uptake.
Oh S, Jeong J, Park B, Kang B, Kim JY, Park S, Lee DH, Jung S, Lee M, Lee W, Yasin M, Seo J, Park ZY, Shin KH, Müller V, Choi IG, Chang IS. Oh S, et al. Among authors: muller v. Trends Biotechnol. 2025 Jan 7:S0167-7799(24)00321-4. doi: 10.1016/j.tibtech.2024.11.008. Online ahead of print. Trends Biotechnol. 2025. PMID: 39794209 Free article.
RAD51 testing in patients with early HER2-negative breast cancer and homologous recombination deficiency: post-hoc analysis of the GeparOla trial.
Villacampa G, Llop-Guevara A, Filmann N, Herencia A, Fasching PA, Karn T, Marmé F, Klare P, Müller V, Stefek A, Schem C, Uleer C, Fehm T, Doering G, Stickeler E, van Mackelenbergh M, Felder B, Nekljudova V, Balmaña J, Denkert C, Loibl S, Serra V. Villacampa G, et al. Among authors: muller v. Clin Cancer Res. 2024 Dec 30. doi: 10.1158/1078-0432.CCR-24-3148. Online ahead of print. Clin Cancer Res. 2024. PMID: 39786436
1,648 results